SQUAWK/NEWS
Account
Theme
Account
Menu
Live News MNA FLASH H impact

Pulmatrix Announces Third Quarter 2026 Financial Results and Progress on Merger

Merger with Eos SENOLYTIX expected to close by end of the yearFRAMINGHAM, Mass., Nov. 17, 2026 // -- Pulmatrix, Inc. ("Pulmatrix", the "Company" or "our") (Nasdaq: PULM), a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prev…

QQQ

Related stories